View in EDS

Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.

Saved in:
Bibliographic Details
Title: Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
Authors: Pearce I; St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom. Electronic address: ian.pearce@rlbuht.nhs.uk., Banerjee S; University Hospital of Wales, Cardiff, United Kingdom., Burton BJ; James Paget University Hospital, Great Yarmouth, United Kingdom., Chakravarthy U; Royal Victoria Hospital, Belfast, United Kingdom., Downey L; Hull and East Yorkshire Eye Hospital, Hull, United Kingdom., Gale RP; York Teaching Hospital, York, United Kingdom., Gibson J; Birmingham Heartlands Hospital, Birmingham, United Kingdom., Pagliarini S; University Hospitals Coventry & Warwickshire, Hospital of St Cross, Rugby, United Kingdom., Patel J; Essex County Hospital, Colchester, United Kingdom., Sivaprasad S; Kings College Hospital, London, United Kingdom., Andrews C; Novartis Pharmaceuticals UK Ltd., Surrey, United Kingdom., Brittain C; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Warburton J; Novartis Pharmaceuticals UK Ltd., Surrey, United Kingdom.
Corporate Authors: RELIGHT Study Group
Source: Ophthalmology [Ophthalmology] 2015 Sep; Vol. 122 (9), pp. 1811-9. Date of Electronic Publication: 2015 Jul 03.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26150052
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pearce+I%22">Pearce I</searchLink>; St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom. Electronic address: ian.pearce@rlbuht.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Banerjee+S%22">Banerjee S</searchLink>; University Hospital of Wales, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Burton+BJ%22">Burton BJ</searchLink>; James Paget University Hospital, Great Yarmouth, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chakravarthy+U%22">Chakravarthy U</searchLink>; Royal Victoria Hospital, Belfast, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Downey+L%22">Downey L</searchLink>; Hull and East Yorkshire Eye Hospital, Hull, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gale+RP%22">Gale RP</searchLink>; York Teaching Hospital, York, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gibson+J%22">Gibson J</searchLink>; Birmingham Heartlands Hospital, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pagliarini+S%22">Pagliarini S</searchLink>; University Hospitals Coventry & Warwickshire, Hospital of St Cross, Rugby, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patel+J%22">Patel J</searchLink>; Essex County Hospital, Colchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sivaprasad+S%22">Sivaprasad S</searchLink>; Kings College Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Andrews+C%22">Andrews C</searchLink>; Novartis Pharmaceuticals UK Ltd., Surrey, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brittain+C%22">Brittain C</searchLink>; F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Warburton+J%22">Warburton J</searchLink>; Novartis Pharmaceuticals UK Ltd., Surrey, United Kingdom.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22RELIGHT+Study+Group%22">RELIGHT Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802443%22">Ophthalmology</searchLink> [Ophthalmology] 2015 Sep; Vol. 122 (9), pp. 1811-9. <i>Date of Electronic Publication: </i>2015 Jul 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802443 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-4713 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201616420%22">01616420 </searchLink><i>NLM ISO Abbreviation: </i>Ophthalmology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26150052
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ophtha.2015.05.038
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1811
    Titles:
      – TitleFull: Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pearce I
      – PersonEntity:
          Name:
            NameFull: Banerjee S
      – PersonEntity:
          Name:
            NameFull: Burton BJ
      – PersonEntity:
          Name:
            NameFull: Chakravarthy U
      – PersonEntity:
          Name:
            NameFull: Downey L
      – PersonEntity:
          Name:
            NameFull: Gale RP
      – PersonEntity:
          Name:
            NameFull: Gibson J
      – PersonEntity:
          Name:
            NameFull: Pagliarini S
      – PersonEntity:
          Name:
            NameFull: Patel J
      – PersonEntity:
          Name:
            NameFull: Sivaprasad S
      – PersonEntity:
          Name:
            NameFull: Andrews C
      – PersonEntity:
          Name:
            NameFull: Brittain C
      – PersonEntity:
          Name:
            NameFull: Warburton J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2015 Sep
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1549-4713
          Numbering:
            – Type: volume
              Value: 122
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Ophthalmology
              Type: main
ResultId 1